Page last updated: 2024-09-05

eslicarbazepine acetate and Pain

eslicarbazepine acetate has been researched along with Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M; Vuković, M1
Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M1

Other Studies

2 other study(ies) available for eslicarbazepine acetate and Pain

ArticleYear
Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception.
    Psychopharmacology, 2020, Volume: 237, Issue:5

    Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Dibenzazepines; Male; Metoclopramide; Mice; Nociception; Pain; Pain Measurement; Rats, Sprague-Dawley; Stress, Psychological; Trigeminal Nerve Diseases

2020
Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors.
    Life sciences, 2018, Dec-01, Volume: 214

    Topics: Adrenergic Antagonists; Analgesics; Animals; Atropine; Cholinergic Antagonists; Dibenzazepines; Formaldehyde; Male; Mice; Naloxone; Narcotic Antagonists; Pain; Receptors, Adrenergic; Receptors, Cholinergic; Receptors, Opioid; Trigeminal Neuralgia; Yohimbine

2018